Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline By GBI Research

1. Pain Management Therapeutics Market to 2019 - Impact of
Patent Expiries Offset by Demand for Neuropathic and
Rheumatoid Pain Medications and Strong Pipeline
GBI Research
Report Highlight

2. About the Publisher
GBI Research provides industry-leading global business intelligence solutions. Our products and services
help companies make better business decisions, win business and position themselves more effectively.
GBI Research publishes more than 100 research reports per annum across a wide range of industries.
Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data
and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified
Analysts across the US, Europe and Asia.
Key report types currently published by GBI Research include:
•Market Intelligence Reports: premium analytical reports based on a combination of market
data, company, deals and project content, industry surveys and additional primary and secondary
research.
•Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies
in a particular industry and geography.
•Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions
on the future of the industry covered.
•Market Profiles: overview-level reports based on market, company and demographic data.
•Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for
different disease indications, based on a detailed database of developmental products.

3. Summary
GBI Research’s report “Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by
Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline“ provides insights and analysis
into the market. Pain is a widespread problem across the world. More than 25% of the total population suffers
from some clinically significant pain in a year. Since pain considerably affects day-to-day activities in life, its
management presents a considerable challenge for physicians. Inadequate pain control remains a major
problem across the world. There is an urgent and unmet need to manage these pain-related problems
accurately. Currently, the management of pain is not efficient due to low diagnosis and prescription rates. In
many cases, such as cancer pain, 50% of the people taking medicines are not satisfied with the results. This is
primarily due to the absence of a perfect pain management solution. Pain management can be most effective
only when the underlying disease conditions are cured. However, there is no treatment that offers absolute
relief for the indications covered in this report. The medications given for these indications are more for
modifying the disease symptoms than offering complete relief from pain. The combination of under-managed
pain, low awareness, and fear of addiction to some classes of pain medication is preventing people suffering
pain from seeking treatment 100% of the time.
Reasons to buy
•Align your product portfolio to the markets with high growth potential.
•Develop market-entry and market expansion strategies by identifying the potential region and therapeutic
segments poised for strong growth.
•Devise a more tailored country strategy through the understanding of key drivers and barriers of the region’s
pain management therapeutics market.
•Develop key strategic initiatives by understanding the key focus areas and top selling pain management
therapeutics molecules of leading companies.
•Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and
strategic partnerships.

4. View This Report
Rapid Cancer Pain Management Growth to Push Global Revenue to $7 Billion by 2019
The cancer pain management market is expected to be the fastest growing segment within the global pain management
therapeutics market, achieving sales of $7 billion by 2019, according to new analysis from business intelligence firm GBI
Research.
The new report* states that the cancer pain management market will increase at a Compound Annual Growth Rate
(CAGR) of 9.1% from 2012 to 2019, followed closely by the post-operative market boasting an estimated increase of 8%
over the forecast period.
It will also become the second largest segment of the overall pain management market, claiming 15%, while the
neuropathic pain management market will continue to hold the largest share of 16%.
According to GBI Research, the growth of the cancer pain management sector will be driven by the increasing global
prevalence of cancer, with drugs such as Fenota, Nucynta, Remoxy and Abstral leading the market.
The significant growth of this treatment area will help boost the growth of the overall pain management market, which
GBI Research estimates will rise from $36 billion in 2012 to $49 billion in 2019, representing a CAGR of 4.6%.
A healthy pipeline will also contribute to climbing market revenue, with neuropathic pain being the key therapy area of
R&D focus, followed by migraine pain, which currently claims 14% of the pipeline.
Despite this level of activity, the overall pain management market will be prevented from growing any further due to the
challenges posed by generic competition, which is expected to increase over the coming years following a series of patent
expiries for top-selling drugs such as Cymbalta, Lyrica and Celebrex (celecoxib).

5. View More Reports from this Publisher
Title Date
Compression Therapy Market to 2019 - Growth due to Increased Awareness in
Venous Disease Management Offset by Reimbursement Issues Sept 1, 2013
Multiple Sclerosis Therapeutics to 2019 - Treatment Diversification, Increasing
Efficacy, and Pipeline Innovation Combine to Drive Growth July 31, 2013
Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced
New Combination Products Forecast to Capture Significant Market Share and Drive
Growth June 30, 2013
Immunoglobulins Market to 2019 - Demand in Primary Immunodeficiency (PI) and
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Potentially
Supplemented by Approvals for Alzheimer’s Disease May 14, 2013
X-ray Systems Market to 2019 - Enhanced Imaging Capability, Better Procedural
Efficiency and Portability to Drive Future Growth of Digital X-ray Systems April 8, 2013
ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD
Offer Hope for Higher Rates of Treatment April 30, 2013
Critical Care Market to 2019 - Growth from Factor Concentrates New Indications
and Increasing Demand for Albumin in Asia-Pacific May 14, 2013
Advanced Wound Management Market to 2019 - Increasing Incidence of Diabetes
Leading to Chronic Wounds in Emerging Countries will Drive Future Growth June 3, 2013

6. MarketResearch.com provides market research solutions to business professionals
seeking to enhance their business goals. We provide a number of business intelligence
solutions, from individual market research reports from over 700 leading global
publishers, to Knowledge Centers where clients can discover deeper business insight
products into a topic over time. Or perhaps your business needs a much wider view across
multiple industries and topics, if so, our Profound solution allows you to select specific
parts (graphs, tables, charts or sections) from different market research reports.
Our Account Managers have in-depth knowledge of the publishers and the various types
of reports in their respective industries. They give you unbiased and qualitative insights on
which reports will best meet your needs.
If you are interested in expanding your business or growing your market share, contact us
to get a free Consultation to Assess your Market Research Needs. We can help tailor a
solution that suits your unique business goals. One of our Account Managers will get right
back in touch with you.
About Us

7. For More on this Report and Additional Research
Visit MarketResearch.com
Or call
1-800-298-5699